CoChat

The Ex Vivo Production of IL-6 and IL-21 by CD4+ T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Neuromyelitis optica (NMO), also known as Devic's disease, is an autoimmune, inflammatory disorder of the central nervous system (CNS) in which the immune system attacks myelin of the neurons located at the optic nerves and spinal cord, thus producing a simultaneous or sequential optic neuritis and myelitis. The objective of this study was evaluated the background T-cell function of patients suffering from neuromyelitis optica (NMO), an autoimmune disorder of the central nervous system. In our study, the in vitro T cell proliferation and the production of Th1 cytokines were significantly lower in cell cultures from NMO patients, as compared with healthy individuals. In contrast, a dominant Th17-like phenotype, associate with higher IL-23 and IL-6 production by LPS-activated monocytes, was observed among NMO patients. The release of IL-21 and IL-6 by polyclonally activated CD4+ T cells was directly correlated to neurological disability. In addition, the in vitro release of IL-21, IL-6 and IL-17 was significantly more resistant to glucocorticoid inhibition in NMO patients. In conclusion, the results indicate dominant Th17-related response in NMO patients that was directly proportional to neurological disability. Furthermore, our results can help to explain why NMO patients trend to be more refractory to corticoid treatment.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10875-012-9780-2

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Research works printed but not linked: 3

  1. Devic E. Myélite aiguë dorse-lombaire de névrite optique, autopsie. Congress Français de méd. Premiere Seance. 1984;9:434–9.
  2. Wingerchuk DM, Hogancamp WF, O’brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 1999;53:1107–14. · DOI · Paper page
  3. Matsuya N, Komori M, Nomura K, Nakane S, Fukudome T, Goto H, Shiraishi H, Wandinger KP, Matsuo H, Kondo T. Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica. Int Immunol. 2011;23(9):565–73. · DOI · Paper page

Cited by

Metadata

Authors
Linhares, U. C., Schiavoni, P. B., Barros, P. O., Kasahara, T. M., Teixeira, B., Ferreira, T. B., Alvarenga, R., Hygino, J., Vieira, M. M. M., Bittencourt, V. C. B., Andrade, R. M., Andrade, A. F., & Bento, C. A. M.
Affiliations
  • Universidade Federal do Estado do Rio de Janeiro (BR)
  • Universidade do Estado do Rio de Janeiro (BR)
Corresponding author
Bento, Cleonice A. M.
Venue
Journal of Clinical Immunology
Published
2012-09-05
Volume
33
Issue
1
Pages
179-189
ISSN
  • 0271-9142 (ISSN-L)
  • 1573-2592
OpenAlex
W1993219034
Cited by
78
References
57
Citations by year
2025: 4 · 2024: 10 · 2023: 3 · 2022: 1 · 2021: 9 · 2020: 8 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 6 · 2013: 8
FWCI
4.84
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Clinical Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
neuromyelitis optica, CD4+ T cells, interleukin-6, IL-21, IL-17, Th17 cells, Th1 cytokines, neurological deficit, glucocorticoid resistance, T cell proliferation, IL-23, optic neuritis, myelitis, autoimmune central nervous system disease
MeSH terms
Interleukin-21, Adult, Cells, Cultured, Female, Humans, Interleukins, Lymphocyte Activation, Male, Middle Aged, Neuromyelitis Optica, CD4-Positive T-Lymphocytes, Interleukin-6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.